In our study’s for 56% (10/18) of all patients with BRCA1 origin ovarian cancer the PV was located in the OCCR published in the study of Rebbeck15, whereas for BRCA2 origin ovarian cancer no PV were located in the ovarian cluster region15. This evidence concerns the gene BRCA2 and ovarian carcinoma.